Padhani AR - Search Results

1

Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting.

Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, Heijmink SW, Hoskin PJ, Kirkham A, Padhani AR, Persad R, Puech P, Punwani S, Sohaib AS, Tombal B, Villers A, van der Meulen J, Emberton M. Dickinson L, et al. Among authors: padhani ar. Eur Urol. 2011 Apr;59(4):477-94. doi: 10.1016/j.eururo.2010.12.009. Epub 2010 Dec 21. Eur Urol. 2011. PMID: 21195536

2

Angiogenesis imaging in the management of prostate cancer.

Padhani AR, Harvey CJ, Cosgrove DO. Padhani AR, et al. Nat Clin Pract Urol. 2005 Dec;2(12):596-607. doi: 10.1038/ncpuro0356. Nat Clin Pract Urol. 2005. PMID: 16474547 Review.

3

Dynamic contrast enhanced MRI in prostate cancer.

Alonzi R, Padhani AR, Allen C. Alonzi R, et al. Among authors: padhani ar. Eur J Radiol. 2007 Sep;63(3):335-50. doi: 10.1016/j.ejrad.2007.06.028. Epub 2007 Aug 8. Eur J Radiol. 2007. PMID: 17689907 Review.

4

Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations.

Padhani AR, Liu G, Koh DM, Chenevert TL, Thoeny HC, Takahara T, Dzik-Jurasz A, Ross BD, Van Cauteren M, Collins D, Hammoud DA, Rustin GJ, Taouli B, Choyke PL. Padhani AR, et al. Neoplasia. 2009 Feb;11(2):102-25. doi: 10.1593/neo.81328. Neoplasia. 2009. PMID: 19186405 Free PMC article.

5

Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans.

Alonzi R, Padhani AR, Maxwell RJ, Taylor NJ, Stirling JJ, Wilson JI, d'Arcy JA, Collins DJ, Saunders MI, Hoskin PJ. Alonzi R, et al. Among authors: padhani ar. Br J Cancer. 2009 Feb 24;100(4):644-8. doi: 10.1038/sj.bjc.6604903. Epub 2009 Feb 3. Br J Cancer. 2009. PMID: 19190629 Free PMC article.

6

Reproducibility and correlation between quantitative and semiquantitative dynamic and intrinsic susceptibility-weighted MRI parameters in the benign and malignant human prostate.

Alonzi R, Taylor NJ, Stirling JJ, d'Arcy JA, Collins DJ, Saunders MI, Hoskin PJ, Padhani AR. Alonzi R, et al. Among authors: padhani ar. J Magn Reson Imaging. 2010 Jul;32(1):155-64. doi: 10.1002/jmri.22215. J Magn Reson Imaging. 2010. PMID: 20578023

7

Antivascular effects of neoadjuvant androgen deprivation for prostate cancer: an in vivo human study using susceptibility and relaxivity dynamic MRI.

Alonzi R, Padhani AR, Taylor NJ, Collins DJ, D'Arcy JA, Stirling JJ, Saunders MI, Hoskin PJ. Alonzi R, et al. Among authors: padhani ar. Int J Radiat Oncol Biol Phys. 2011 Jul 1;80(3):721-7. doi: 10.1016/j.ijrobp.2010.02.060. Epub 2010 Jul 12. Int J Radiat Oncol Biol Phys. 2011. PMID: 20630668

8

Diffusion magnetic resonance imaging in cancer patient management.

Padhani AR. Padhani AR. Semin Radiat Oncol. 2011 Apr;21(2):119-40. doi: 10.1016/j.semradonc.2010.10.004. Semin Radiat Oncol. 2011. PMID: 21356480 Review.

9

Clinical utility of diffusion-weighted magnetic resonance imaging in prostate cancer.

Afaq A, Koh DM, Padhani A, van As N, Sohaib SA. Afaq A, et al. BJU Int. 2011 Dec;108(11):1716-22. doi: 10.1111/j.1464-410X.2011.10256.x. Epub 2011 Jun 1. BJU Int. 2011. PMID: 21631696 Review.

10

Phase Ib trial of radiotherapy in combination with combretastatin-A4-phosphate in patients with non-small-cell lung cancer, prostate adenocarcinoma, and squamous cell carcinoma of the head and neck.

Ng QS, Mandeville H, Goh V, Alonzi R, Milner J, Carnell D, Meer K, Padhani AR, Saunders MI, Hoskin PJ. Ng QS, et al. Among authors: padhani ar. Ann Oncol. 2012 Jan;23(1):231-237. doi: 10.1093/annonc/mdr332. Epub 2011 Jul 15. Ann Oncol. 2012. PMID: 21765046 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

318 results

Search Page